Effect of calcium channel modulators on temperature regulation in ovariectomized rats

Pharmacology Biochemistry and Behavior

Volumn 80, Issue 3, 2005, Pages 511-520

  Leventhal, Liza ^a   Cosmi, Scott ^a   Deecher, Darlene ^a  

^a PFIZER INC   (United States)

Author keywords

Circadian rhythm; Estrogen; Hot flush; Menopause; Thermoregulation; Vasomotor symptoms

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; ESTROGEN; GABAPENTIN; NIFEDIPINE; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EVALUATION; FEMALE; HOT FLUSH; MENOPAUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SKIN TEMPERATURE; TELEMETRY; THERMOREGULATION; VASOMOTOR DISORDER;

RODENTIA;

EID: 14544292889     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.01.005     Document Type: Article

References (37)

1. J.M. Baeyens, E. Esposito, G. Ossowska, and R. Samanin Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats Eur. J. Pharmacol. 137 1987 9 13
2. D.B. Beleslin, A.H. Rezvani, and R.D. Myers Divergent action of verapamil perfused in two hypothalamic areas on body temperature of the cat Neurosci. Lett. 57 1985 307 312
3. H.H.G. Berendsen The role of serotonin in hot flushes Maturitas 36 2000 155 164
4. H.H.G. Berendsen, A.H.J. Weekers, and H.J. Kloosterboer Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats Eur. J. Pharmacol. 419 2001 47 54
5. G. Blackburn-Munro, C.H. Brown, I.D. Neumann, R. Landgraf, and J.A. Russell Verapamil prevents withdrawal excitation of oxytocin neurones in morphine-dependent rats Neuropharmacology 39 2000 1596 1607
6. F. Bongianni, V. Carla, F. Moroni, and D.E. Pellegrini-Giampietro Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats Br. J. Pharmacol. 88 1986 561 567
7. 2+ channel subunit from porcine brain: development of a radioligand binding assay for alpha 2 delta subunits using [3H]leucine Anal. Biochem. 255 1998 236 243
8. 2+ channel antagonists Trends Pharmacol. Sci. 13 1992 256 262 [Review, 36 refs]
9. Y. Erlik, D.R. Meldrum, and H.L. Judd Estrogen levels in postmenopausal women with hot flashes Obstet. Gynecol. 59 1982 403 407
10. N.S. Gee, J.P. Brown, V.U. Dissanayake, J. Offord, R. Thurlow, and G.N. Woodruff The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel J. Biol. Chem. 271 1996 5768 5776
11. H.C. Gong, J. Hang, W. Kohler, L. Li, and T.Z. Su Tissue-specific expression and gabapentin-binding properties of calcium channel alpha2delta subunit subtypes J. Membr. Biol. 184 2001 35 43
12. T.J. Guttuso Jr. Gabapentin's effects on hot flashes and hypothermia Neurology 54 2000 2161 2163
13. T. Guttuso Jr., R. Kurlan, M.P. McDermott, and K. Kieburtz Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial Obstet. Gynecol. 101 2003 337 345 [see comment]
14. M.J. Katovich, J.W. Simpkins, L.A. Berglund, and J. O'Meara Regional skin temperature changes in a rat model for the menopausal hot flush Maturitas 8 1986 67 76
15. L.R. Laufer, Y. Erlik, D.R. Meldrum, and H.L. Judd Effect of clonidine on hot flashes in postmenopausal women Obstet. Gynecol. 60 1982 583 586
16. P. Lomax, and E. Schonbaum Postmenopausal hot flushes and their management Pharmacol. Ther. 57 1993 347 358
17. C.L. Loprinzi, R.M. Goldberg, J.R. O'Fallon, S.K. Quella, A.W. Miser, and L.A. Mynderse Transdermal clonidine for ameliorating post-orchiectomy hot flashes J. Urol. 151 1994 634 636
18. C.L. Loprinzi, T.M. Pisansky, R. Fonseca, J.A. Sloan, K.M. Zahasky, and S.K. Quella Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors J. Clin. Oncol. 16 1998 2377 2381
19. C.L. Loprinzi, J.W. Kugler, J.A. Sloan, J.A. Mailliard, B.I. LaVasseur, and D.L. Barton Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Lancet 356 2000 2059 2063
20. C.L. Loprinzi, D.L. Barton, and D. Rhodes Management of hot flashes in breast-cancer survivors Lancet Oncol. 2 2001 199 204
21. C.L. Loprinzi, J.A. Sloan, E.A. Perez, S.K. Quella, P.J. Stella, and J.A. Mailliard Phase III evaluation of fluoxetine for treatment of hot flashes J. Clin. Oncol. 20 2002 1578 1583
22. L. Loprinzi, D.L. Barton, J.A. Sloan, K.M. Zahasky, A.R. de Smith, and S. Pruthi Pilot evaluation of gabapentin for treating hot flashes Mayo Clin. Proc. 77 2002 1159 1163 [comment]
23. Y.P. Maneuf, M.I. Gonzalez, K.S. Sutton, F.Z. Chung, R.D. Pinnock, and K. Lee Cellular and molecular action of the putative GABA-mimetic, gabapentin Cell. Mol. Life Sci. 60 2003 742 750 [Review, 93 refs]
24. S.M. McKinlay, and M. Jefferys The menopausal syndrome Br. J. Prev. Soc. Med. 28 1974 108 115
25. I. Merchenthaler, J.M. Funkhouser, J.M. Carver, S.G. Lundeen, K. Ghosh, and R.C. Winneker The effect of estrogens and antiestrogens in a rat model for hot flush Maturitas 30 1998 307 316
26. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat Eur. J. Pharmacol. 352 1998 189 197
27. M. Palmi, and G. Sgaragli Hyperthermia induced in rabbits by organic calcium antagonists Pharmacol. Biochem. Behav. 34 1989 325 330
28. K.J. Pandya, R.F. Raubertas, P.J. Flynn, H.E. Hynes, R.J. Rosenbluth, and J.J. Kirshner Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study [comment] Ann. Intern. Med. 132 2000 788 793
29. T.P. Piepponen, A. Zharkovsky, T. Kivastik, and L. Ahtee Effects of morphine in rats withdrawn from repeated nifedipine administration Eur. J. Pharmacol. 365 1999 159 164
30. A.H. Rezvani, D.B. Beleslin, and R.D. Myers Neuroanatomical mapping of hypothalamic regions mediating verapamil hyper- and hypothermia in the cat [erratum appears in Brain Res Bull 1986 Nov;17(5):731] Brain Res. Bull. 17 1986 249 254
31. M.A. Rose, and P.C. Kam Gabapentin: pharmacology and its use in pain management [Review, 131 refs] Anaesthesia 57 2002 451 462
32. P. Schnur, M. Espinoza, R. Flores, S. Ortiz, S. Vallejos, and M. Wainwright Blocking naloxone-precipitated withdrawal in rats and hamsters Pharmacol. Biochem. Behav. 43 1992 1093 1098
33. J.W. Simpkins, M.J. Katovich, and I.C. Song Similarities between morphine withdrawal in the rat and the menopausal hot flush Life Sci. 32 1983 1957 1966
34. K. Sipe, L. Leventhal, K. Burroughs, S. Cosmi, G.H. Johnston, and D.C. Deecher Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction Brain Res. 1028 2004 191 202
35. V. Stearns, C. Isaacs, J. Rowland, J. Crawford, M.J. Ellis, and R. Kramer A pilot trial assessing the efficacy of paroxetine hydrochloride (paxil) in controlling hot flashes in breast cancer survivors [comment] Ann. Oncol. 11 2000 17 22
36. V. Stearns, K.L. Beebe, M. Iyengar, and E. Dube Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial JAMA 289 2003 2827 2834
37. M.A. Weitzner, J. Moncello, P.B. Jacobsen, and S. Minton A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer J. Pain Symp. Manage. 23 2002 337 345